{"id":"spinal-fluid-collection","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T04:45:47.884Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:37:15.692335+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07494812","phase":"NA","title":"Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-15","conditions":"NPH (Normal Pressure Hydrocephalus)","enrollment":10},{"nctId":"NCT04314401","phase":"","title":"National Cancer Institute \"Cancer Moonshot Biobank\"","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-11-11","conditions":"Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8","enrollment":1600},{"nctId":"NCT03739814","phase":"PHASE2","title":"Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-05-08","conditions":"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia","enrollment":84},{"nctId":"NCT04529252","phase":"","title":"Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-07-17","conditions":"Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease","enrollment":1000},{"nctId":"NCT00090662","phase":"","title":"Collection of Data and Samples From Healthy Donors for Use in Translational Research","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-12-09","conditions":"Healthy Volunteer","enrollment":150},{"nctId":"NCT05212272","phase":"NA","title":"MRI in High-Grade Glioma Patients Undergoing Chemoradiation","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":16},{"nctId":"NCT07435649","phase":"NA","title":"Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection","status":"NOT_YET_RECRUITING","sponsor":"Delve Bio, Inc.","startDate":"2026-03-01","conditions":"Central Nervous System Infection","enrollment":400},{"nctId":"NCT06054854","phase":"","title":"Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2024-06-13","conditions":"Lung Nodule, Lung Cancer","enrollment":3000},{"nctId":"NCT07483476","phase":"","title":"Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Acute Lymphoblastic Leukemia ALL","enrollment":205},{"nctId":"NCT05286684","phase":"NA","title":"Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2023-01-04","conditions":"Breast Cancer","enrollment":7},{"nctId":"NCT07480187","phase":"NA","title":"Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda Ospedaliera di Perugia","startDate":"2023-05-20","conditions":"Parkinson Disease, Synucleinopathy, Alzheimer Disease","enrollment":340},{"nctId":"NCT07478926","phase":"NA","title":"Flow Detection in Open and Closed Shunt Valve Periods","status":"RECRUITING","sponsor":"Rhaeos, Inc.","startDate":"2026-01-27","conditions":"Hydrocephalus","enrollment":55},{"nctId":"NCT07476781","phase":"NA","title":"CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-12-12","conditions":"Solid Tumor Malignancies, Brain Metastasases, Leptomeningeal Disease (LMD)","enrollment":60},{"nctId":"NCT07478471","phase":"","title":"Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax","status":"NOT_YET_RECRUITING","sponsor":"Emergent BioSolutions","startDate":"2027-05","conditions":"Infections, Bacterial","enrollment":10},{"nctId":"NCT07137494","phase":"PHASE1","title":"A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-08-14","conditions":"Primary Central Nervous System (CNS) Lymphoma, Secondary Central Nervous System Lymphoma","enrollment":12},{"nctId":"NCT07226453","phase":"PHASE2","title":"Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-04","conditions":"Posterior Fossa Ependymal Tumor","enrollment":30},{"nctId":"NCT05453500","phase":"PHASE2","title":"Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-03-27","conditions":"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","enrollment":30},{"nctId":"NCT03252912","phase":"NA","title":"Study in Leptomeningeal Metastases of Breast Cancer","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2017-01-06","conditions":"Breast Cancer","enrollment":51},{"nctId":"NCT07468136","phase":"PHASE1, PHASE2","title":"Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04-24","conditions":"Anaplastic Oligodendroglioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4","enrollment":33},{"nctId":"NCT06894979","phase":"PHASE1","title":"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-06-18","conditions":"Childhood Astrocytoma, Childhood Diffuse Intrinsic Pontine Glioma, Childhood Diffuse Midline Glioma","enrollment":54},{"nctId":"NCT07466316","phase":"PHASE3","title":"A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-22","conditions":"Rhabdomyosarcoma","enrollment":342},{"nctId":"NCT07177885","phase":"","title":"Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-03-05","conditions":"Migraine","enrollment":144},{"nctId":"NCT04819737","phase":"NA","title":"Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-07-18","conditions":"Multiple Sclerosis (MS)","enrollment":10},{"nctId":"NCT07447076","phase":"PHASE2","title":"Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-05-01","conditions":"Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS","enrollment":29},{"nctId":"NCT06322602","phase":"NA","title":"Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-02-28","conditions":"Brain Neoplasms","enrollment":20},{"nctId":"NCT07442981","phase":"","title":"Preoperative Dietary Fat Consumption and Baseline Inflammatory Markers","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2025-03-25","conditions":"Fat Consumption, Inflammatory Markers","enrollment":62},{"nctId":"NCT07443514","phase":"NA","title":"Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2022-01-01","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":3},{"nctId":"NCT02402244","phase":"","title":"Project: Every Child for Younger Patients With Cancer","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2015-11-03","conditions":"Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm","enrollment":75000},{"nctId":"NCT07432113","phase":"NA","title":"Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Health Science of Porto Alegre","startDate":"2026-03-16","conditions":"Meningitis, Encephalitic Infection, Encephalitis","enrollment":182},{"nctId":"NCT05977712","phase":"","title":"Circadian Rhythm and Other Factors in Memory Clinic Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-03-06","conditions":"Dementia","enrollment":1200},{"nctId":"NCT06131801","phase":"","title":"Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-11-15","conditions":"Hematologic Malignancy, Leukemia, Lymphoma","enrollment":30},{"nctId":"NCT04012411","phase":"NA","title":"Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2020-03-03","conditions":"Huntington Disease","enrollment":135},{"nctId":"NCT05419076","phase":"PHASE2","title":"A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-06-10","conditions":"Lung Cancer, Lung Cancer Metastatic, Brain Metastases","enrollment":62},{"nctId":"NCT05890781","phase":"NA","title":"Engineering Immune Organoids to Study Pediatric Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-05-12","conditions":"Brain Tumor, Kidney Tumor, Neuroblastoma","enrollment":108},{"nctId":"NCT07398170","phase":"NA","title":"Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Meningioma","enrollment":15},{"nctId":"NCT02177721","phase":"PHASE4","title":"Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario","status":"NOT_YET_RECRUITING","sponsor":"Emergent BioSolutions","startDate":"2027-01","conditions":"Infections, Bacterial","enrollment":100},{"nctId":"NCT04798651","phase":"NA","title":"Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2021-09-30","conditions":"Multiple Sclerosis, Clinically Isolated Syndrome","enrollment":150},{"nctId":"NCT05854433","phase":"","title":"Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-04-26","conditions":"Myotonic Dystrophy Type 2, Myotonic Dystrophy Type 1","enrollment":100},{"nctId":"NCT06321965","phase":"NA","title":"Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-07-24","conditions":"Spinal Muscular Atrophy","enrollment":60},{"nctId":"NCT04401774","phase":"PHASE2","title":"Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-05-22","conditions":"Primary Central Nervous System Lymphoma (PCNSL)","enrollment":14},{"nctId":"NCT06629324","phase":"PHASE2","title":"Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2024-10-15","conditions":"Autism Spectrum Disorder","enrollment":58},{"nctId":"NCT02770482","phase":"NA","title":"Amyloid Beta-peptide 1-40 and Alzheimer's Disease","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2014-06","conditions":"Alzheimer Disease","enrollment":204},{"nctId":"NCT07346950","phase":"","title":"The Effect of Autoreactive Autoantibodies on Peripheral and Central Disease Mechanisms in Fibromyalgia.","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2022-11-30","conditions":"Fibromyalgia","enrollment":164},{"nctId":"NCT06496451","phase":"","title":"Measurement of Frataxin mRNA in Biofluids","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-08-08","conditions":"Friedreich Ataxia","enrollment":10},{"nctId":"NCT06547099","phase":"","title":"Study to Understand Novel Biomarkers in Researching Dementia","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-08-14","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Dementia","enrollment":1800},{"nctId":"NCT05370079","phase":"NA","title":"Control Cohort CTRL COH","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-08-08","conditions":"Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis","enrollment":350},{"nctId":"NCT03025256","phase":"PHASE1","title":"Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-05-02","conditions":"Acral Lentiginous Melanoma, Central Nervous System Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":71},{"nctId":"NCT06861244","phase":"PHASE2","title":"Embryonal Tumor With Multilayered Rosettes","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-06","conditions":"Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos","enrollment":70},{"nctId":"NCT07314762","phase":"","title":"Elderly Patients Undergoing Surgery During Perioperative Period","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2023-12-30","conditions":"Postoperative Complications, Elderly, Postoperative Delirium (POD)","enrollment":1200},{"nctId":"NCT04453917","phase":"NA","title":"Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2021-02-23","conditions":"Progressive Multifocal Leukoencephalopathy","enrollment":22},{"nctId":"NCT06526364","phase":"","title":"Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-12-10","conditions":"Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive","enrollment":100},{"nctId":"NCT06816979","phase":"NA","title":"Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-01-15","conditions":"Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8","enrollment":40},{"nctId":"NCT02855476","phase":"","title":"HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease","status":"RECRUITING","sponsor":"University College, London","startDate":"2017-01-01","conditions":"Huntington's Disease","enrollment":2500},{"nctId":"NCT05009992","phase":"PHASE2","title":"Combination Therapy for the Treatment of Diffuse Midline Gliomas","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-20","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma","enrollment":360},{"nctId":"NCT04852354","phase":"","title":"Tissue Collection for Drug Screening and Bioanalysis","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2020-07-22","conditions":"Central Nervous System Tumor","enrollment":500},{"nctId":"NCT03952637","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2019-08-19","conditions":"Lysosomal Diseases, Gangliosidosis, GM1","enrollment":54},{"nctId":"NCT06518057","phase":"PHASE2","title":"Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-03-03","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":22},{"nctId":"NCT06023446","phase":"","title":"Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Davis","startDate":"2023-09-29","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":100},{"nctId":"NCT05615415","phase":"","title":"Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-02-15","conditions":"Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection","enrollment":30},{"nctId":"NCT05746325","phase":"NA","title":"Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-04-07","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Leptomeninges","enrollment":5},{"nctId":"NCT07213440","phase":"NA","title":"Identification of Early Markers for ALS","status":"RECRUITING","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2024-09-30","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":60},{"nctId":"NCT05516719","phase":"","title":"Longitudinal Investigation of I2BS in PD","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2021-11-01","conditions":"Parkinson's, Parkinson Disease, Parkinson's Disease","enrollment":44},{"nctId":"NCT05516732","phase":"","title":"Serotonin Release in Premotor and Motor PD","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2022-07-01","conditions":"Parkinson Disease, Parkinson's, Parkinson's Disease","enrollment":42},{"nctId":"NCT03974204","phase":"NA","title":"Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.","status":"WITHDRAWN","sponsor":"Centre Oscar Lambret","startDate":"2019-07","conditions":"Breast Cancer, Leptomeningeal Metastasis","enrollment":""},{"nctId":"NCT07184073","phase":"","title":"Cognitive Fraility and Biomarkers in Older Patients","status":"COMPLETED","sponsor":"Baskent University","startDate":"2021-06-03","conditions":"Cognitive Impairment, Frail Older Adults, Orthopaedic Surgery","enrollment":129},{"nctId":"NCT04496830","phase":"","title":"SPINCOMS Biomarker Study","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-06-15","conditions":"Multiple Sclerosis","enrollment":161},{"nctId":"NCT04546399","phase":"PHASE2","title":"A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-17","conditions":"Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia","enrollment":461},{"nctId":"NCT07153211","phase":"NA","title":"Analysis of Selected Biochemical Parameters in Cerebrospinal Fluid and Peripheral Blood in the Treatment of Neuropathic Pain Using Spinal Cord Stimulation (SCS)","status":"RECRUITING","sponsor":"Pawel Sokal","startDate":"2022-11-01","conditions":"Neuropathic Pain, Chronic Pain, Spinal Cord Stimulation (SCS)","enrollment":30},{"nctId":"NCT07026552","phase":"","title":"Proteomic and Histological Analysis of Ligamentum Flavum in Lumbar Stenosis","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-06-15","conditions":"Spinal Stenosis of Lumbar Region, Spine Degeneration","enrollment":100},{"nctId":"NCT06303349","phase":"NA","title":"Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2024-05-07","conditions":"Cerebral Vasospasm","enrollment":155},{"nctId":"NCT06224920","phase":"","title":"Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2017-01-01","conditions":"Alzheimer Disease, Corticobasal Syndrome","enrollment":140},{"nctId":"NCT06880406","phase":"NA","title":"Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2025-07-01","conditions":"Alzheimer Disease","enrollment":170},{"nctId":"NCT01909492","phase":"","title":"Measurement of Relaxin Peptide in Multiple Sclerosis (MS)","status":"COMPLETED","sponsor":"Providence Health & Services","startDate":"2013-09-20","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":30},{"nctId":"NCT05620914","phase":"PHASE2","title":"A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases","status":"WITHDRAWN","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2025-07","conditions":"Brain Metastases, Adult","enrollment":""},{"nctId":"NCT06062446","phase":"NA","title":"A Prospective Study of a Modified Lumbar Puncture (LP) Procedure That Reduces Post-Lumbar Puncture Headaches (PLPH) in Patients","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-11-08","conditions":"Post-Lumbar Puncture Headache","enrollment":100},{"nctId":"NCT04957901","phase":"","title":"The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-12-01","conditions":"Lymphoma","enrollment":60},{"nctId":"NCT05036564","phase":"NA","title":"Diagnosis; Objective RespOnse; THErApy","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2020-10-16","conditions":"Primary CNS Lymphoma","enrollment":70},{"nctId":"NCT06711952","phase":"NA","title":"German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)","status":"RECRUITING","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2023-02-01","conditions":"Alzheimer Disease, Subjective Cognitive Decline","enrollment":300},{"nctId":"NCT04097158","phase":"","title":"Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2019-10-08","conditions":"Amyotrophic Lateral Sclerosis","enrollment":160},{"nctId":"NCT05927610","phase":"NA","title":"Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-06-19","conditions":"Glioblastoma","enrollment":""},{"nctId":"NCT06762080","phase":"PHASE1, PHASE2","title":"Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis","status":"RECRUITING","sponsor":"Guangzhou Medical University","startDate":"2025-03-07","conditions":"Leptomeningeal Metastasis","enrollment":36},{"nctId":"NCT06809517","phase":"PHASE1, PHASE2","title":"Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis","status":"RECRUITING","sponsor":"Guangzhou Medical University","startDate":"2025-03-18","conditions":"Leptomeningeal Metastasis, Intrathecal Drug Delivery","enrollment":34},{"nctId":"NCT06809530","phase":"PHASE1, PHASE2","title":"Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis","status":"RECRUITING","sponsor":"Guangzhou Medical University","startDate":"2025-03-17","conditions":"Leptomeningeal Metastasis, Pemetrexed, PD-1 Inhibitor","enrollment":34},{"nctId":"NCT05288842","phase":"","title":"Tanycytes in Alzheimer's Disease and Frontotemporal Dementia","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2022-09-06","conditions":"Alzheimer Disease, Frontotemporal Dementia","enrollment":102},{"nctId":"NCT06772155","phase":"","title":"Security and Effectiveness Assessment of Locking Systems in Ventriculostomy for Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Meditech Foundation","startDate":"2025-07-05","conditions":"Traumatic Brain Injuries, Intracranial Hypertension","enrollment":292},{"nctId":"NCT01862107","phase":"","title":"Cerebrospinal Fluid Collection and Repository Storage","status":"TERMINATED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2013-07-29","conditions":"Nervous System Diseases","enrollment":51},{"nctId":"NCT06673966","phase":"","title":"Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-01-10","conditions":"Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Mental Disorders","enrollment":200},{"nctId":"NCT06928649","phase":"NA","title":"Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2024-03-13","conditions":"Sepsis, Trauma Related Injuries, Subarachnoid Haemorrhage (SAH)","enrollment":600},{"nctId":"NCT05837130","phase":"EARLY_PHASE1","title":"Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers","status":"COMPLETED","sponsor":"Servier","startDate":"2022-07-11","conditions":"Parkinson Disease","enrollment":45},{"nctId":"NCT04692324","phase":"","title":"Cerebrospinal Fluid Biomarkers for Brain Tumors","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-01-14","conditions":"Central Nervous System Neoplasm","enrollment":300},{"nctId":"NCT05430490","phase":"","title":"Cannabis, HIV and Mental Processing Systems","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-03-23","conditions":"HIV Infections, Cannabis","enrollment":320},{"nctId":"NCT06323408","phase":"","title":"Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Regensburg","startDate":"2025-05","conditions":"Glioma, Malignant, Embryonal Tumor, Medulloblastoma","enrollment":72},{"nctId":"NCT04818060","phase":"","title":"Preparing for Prevention of Huntington's Disease (PREVENT-HD)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-09-13","conditions":"Huntington Disease","enrollment":258},{"nctId":"NCT06861218","phase":"PHASE2","title":"Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2025-04","conditions":"Leptomeningeal Metastases","enrollment":42},{"nctId":"NCT06048523","phase":"NA","title":"Prospective Cohort Study of Neurogenetic Diseases","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-18","conditions":"Genetic Disease, Nervous System Diseases","enrollment":150},{"nctId":"NCT05257967","phase":"NA","title":"CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease","status":"RECRUITING","sponsor":"British Columbia Cancer Agency","startDate":"2022-07-18","conditions":"EGFR Activating Mutation, Leptomeningeal Metastasis, Non Small Cell Lung Cancer","enrollment":10},{"nctId":"NCT06120049","phase":"PHASE2, PHASE3","title":"[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD","status":"RECRUITING","sponsor":"prof. dr. Koen Van Laere","startDate":"2024-01-19","conditions":"Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy","enrollment":113},{"nctId":"NCT04233099","phase":"","title":"Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)","status":"COMPLETED","sponsor":"Fondazione Don Carlo Gnocchi Onlus","startDate":"2019-07-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":126},{"nctId":"NCT04421846","phase":"NA","title":"Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-11-25","conditions":"Status Epilepticus, Dysimmune Encephalopathy","enrollment":400},{"nctId":"NCT06769815","phase":"NA","title":"Host Immunity, Plasmodium and Pathogens Co-Infections","status":"NOT_YET_RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-02-15","conditions":"Malaria, Bacterial Co-infection","enrollment":2000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"spinal fluid collection","genericName":"spinal fluid collection","companyName":"CHU de Reims","companyId":"chu-de-reims","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":12,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:37:15.692335+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}